FDA Inspection 1282090 — CorneaGen, LLC
The FDA completed an inspection of CorneaGen, LLC on Sep 10, 2025 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 10, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- South San Francisco, CA (United States)